KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $2.4 billion.

  • Boston Scientific's Other Non-Current Liabilities rose 2860.96% to $2.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.4 billion, marking a year-over-year increase of 2860.96%. This contributed to the annual value of $2.4 billion for FY2025, which is 2860.96% up from last year.
  • As of Q4 2025, Boston Scientific's Other Non-Current Liabilities stood at $2.4 billion, which was up 2860.96% from $2.4 billion recorded in Q3 2025.
  • Boston Scientific's Other Non-Current Liabilities' 5-year high stood at $2.4 billion during Q4 2025, with a 5-year trough of $1.8 billion in Q2 2024.
  • For the 5-year period, Boston Scientific's Other Non-Current Liabilities averaged around $2.1 billion, with its median value being $2.0 billion (2022).
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first tumbled by 1655.05% in 2022, then soared by 3238.89% in 2025.
  • Quarter analysis of 5 years shows Boston Scientific's Other Non-Current Liabilities stood at $2.2 billion in 2021, then fell by 8.33% to $2.0 billion in 2022, then fell by 3.34% to $2.0 billion in 2023, then fell by 4.93% to $1.9 billion in 2024, then rose by 28.61% to $2.4 billion in 2025.
  • Its Other Non-Current Liabilities stands at $2.4 billion for Q4 2025, versus $2.4 billion for Q3 2025 and $2.4 billion for Q2 2025.